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Abstract: Autophagy is a cellular process that catabolizes cytoplasmic components and 
maintains energy homeostasis. As a stress response, the autophagy machinery interconnects 
a  wide  range  of  cellular  pathways,  enhancing  the  spread  of  certain  pathogens  while 
limiting others, and has become a highly active research area over the past several years. 
Independent  laboratories  have  recently  reported  that  autophagy  vesicles  accumulate  in 
hepatitis C virus (HCV) infected cells and that autophagy proteins can function as proviral 
factors  required  for  HCV  replication.  In  this  review,  we  summarize  what  is  currently 
known  about  the  interplay  between  autophagy  and  HCV  and  the  possible  mechanisms 
whereby autophagy proteins might favor HCV propagation. 
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1. Introduction 
Autophagy is a homeostatic process by which cells break down and recycle cytoplasmic organelles 
and  protein  aggregates  that  are  too  large  to  be  degraded  by  the  proteasome.  During  autophagy, 
cytoplasmic components are sequestered by a membrane, called a phagophore or isolation membrane, 
that expands to form double-membrane vesicles termed autophagosomes. Autophagosomes can fuse 
with vesicles of the endocytic pathway to form amphisomes that eventually fuse with lysosomes where 
the sequestered material is degraded. The core molecular machinery of autophagy―the autophagy 
(ATG) proteins―orchestrate this dynamic membrane rearrangement [1]. Our current understanding of 
the molecular regulation of the autophagy pathway has been described in detail in other reviews (e.g., 
see [1-5]). The autophagy machinery is thought to have evolved as a stress response that permits 
unicellular eukaryotic organisms to survive, probably by regulating energy availability and organelle 
quality. The same autophagy machinery has diversified functions in higher eukaryotic organisms so as 
to regulate multiple defensive responses to various forms of stress. It notably plays an essential role in 
the removal of potentially pathogenic protein aggregates from the cell during aging or degenerative 
processes. Not surprisingly, the autophagy machinery can also degrade components of intracellular 
microorganisms,  including  viruses,  bacteria  and  protozoa  (reviewed  in  [6]).  Additionally,  the 
autophagy machinery can play a pivotal role in the host response against these infections. Autophagy 
proteins  serve  to  balance  the  induction  and  suppression  of  antiviral  and  inflammatory  responses, 
thereby  regulating  the  protective  and  potentially  pathogenic  consequences  of  these  responses 
(reviewed in [7]). Autophagy is activated by cellular stress, including that induced by viral infection. 
However, certain viruses can antagonize its initiation as well as its maturation (reviewed in [6]). This 
complex  reciprocal  relationship  between  viruses  and  the  autophagy  machinery  may  influence  the 
severity and the outcome of an infection, including whether it resolves or persists (reviewed in [6]). 
The  hepatitis  C  virus  (HCV)  is  a  major  causative  agent  of  acute  and  chronic  liver  diseases 
worldwide.  130–170  million  people  are  persistently  infected  with  HCV  and  have  a  high  risk  of 
developing liver cirrhosis and hepatocellular carcinoma [8]. A hallmark of HCV is its high propensity 
to persist with up to 80–90% of infected individuals failing to eliminate the virus. A prophylactic 
vaccine  is  not  available  and  its  development  has  been  seriously  hampered  by  the  high  genetic 
variability of the virus.  Treatment options  for  chronic HCV infection  are also limited.  Indeed  the 
current  therapy,  a  combination  of  polyethylene  glycol-conjugated  interferon-α  and  ribavirin,  is 
associated with numerous side effects, has many contraindications and on average only approximately 
50% of those patients who can qualify for treatment, tolerate its toxicity, and complete six months of 
therapy are cured [9]. A large number of direct-acting antiviral agents are under development at this 
time with the hope of eventually  replacing interferon  and  ribavirin as the treatment of choice  for 
chronic HCV infection.  
HCV, a single stranded positive sense RNA virus, is a member of the Flaviviridae family. Its 9.6-kb 
RNA  genome  encodes  a  long  open  reading  frame  that  is  co-  and  post-translationally  cleaved  by 
cellular and viral proteases (reviewed in [10]) into structural proteins (core, E1, E2) that constitute the 
major viral components of infectious particles,  and non-structural proteins (p7, NS2, NS3, NS4A, 
NS4B, NS5A and NS5B) that are required at multiple levels of the virus life cycle including viral RNA 
replication  [11]  and  infectious  particle  assembly  [12].  The  single  open  reading  frame  is  located Viruses 2011, 3                                       
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between two untranslated regions (UTR) that contain RNA sequences essential for RNA translation 
and  replication  [13-15].  HCV  infection  is  initiated  by  binding  of  enveloped  viral  particles  to  cell 
surface receptors, followed by their internalization into endosomes in a clathrin-dependent manner 
(reviewed in [16,17]). Release of the plus-strand RNA viral genome into the cytoplasm is thought to 
occur after low pH-induced fusion of the viral and endosomal membranes, a process that is mediated 
by the viral envelope glycoproteins [16,18,19]. Translation of the plus-stranded viral RNA genome is 
driven by an internal ribosomal entry site (IRES) sequence present within the 5′ UTR [10]. Subsequent 
cleavage  of  the  polyprotein  into  individual  viral  proteins  leads  to  establishment  of  replication 
complexes in ER-derived membranous compartments where viral RNA replication occurs via minus 
strand viral RNA synthesis [10]. Progeny viral genomes are either translated to produce additional 
viral proteins or packaged to assemble progeny infectious virus. Viral particle assembly is thought to 
occur in an ER-derived compartment in close proximity to lipid droplets (reviewed in [12,20,21]). The 
HCV assembly process is dependent not only on structural and non-structural proteins (p7, NS2, NS3 
and  NS5A)  [22-32]  but  also  on  many  cellular  factors  including  those  involved  in  lipoprotein 
biosynthesis [33-40].  
Recently, several papers have been published that shed light on the ability of HCV to modulate the 
autophagy pathway  and on the capacity of several autophagy proteins  to positively regulate HCV 
productive infection [41-46]. Here we review these recent advances, present our understanding of the 
mechanism(s) by which autophagy proteins can enhance HCV infection, and discuss the implications 
of those concepts for the survival of HCV in infected cells. 
2. HCV Regulates the Autophagy Pathway  
A  broad  spectrum  of  DNA  and  RNA  viruses  induce  the  accumulation  of  autophagosomes  or 
autophagy-related  vesicles  in  infected  cells  [41,42,46-69].  Ait-Goughoulte  and  colleagues  initially 
showed that serial passage of an HCV genotype 1a isolate (H77) in immortalized human hepatocytes 
provokes accumulation of microtubule-associated protein 1 light chain 3 β (LC3B)-positive vesicles, a 
characteristic feature of autophagic vesicles [59]. The occurrence of increased numbers of autophagy 
vesicles in HCV infected cells has been confirmed and extended to other cell types and viral strains 
using different detection methods [41-44,46,68]. This phenotype does not require HCV cell entry nor 
the production of infectious virus, since human hepatoma-derived cell lines containing a replication-
competent  subgenomic  HCV  genome  that  cannot  produce  infectious  virus  particles  display  the 
characteristic features of autophagic vesicle accumulation [46,68]. Furthermore, since degradation of 
long-lived proteins and p62/sequestosome 1, a polyubiquitin binding protein known to be degraded via 
autophagy [70], were not enhanced in HCV replicating cells, Sir et al., proposed that autophagy seems 
incomplete  in  such  cells  [46].  In  contrast,  Ke  and  Chen  demonstrated  that  autophagic  vesicle 
maturation and autolysosome formation occur in HCV infected cells [44]. This apparent discrepancy 
might reflect differences in the kinetics and magnitude of HCV replication and protein expression in 
the conflicting experiments [44,46] or the possibility that infected cells might contain specific subsets 
of autophagic vesicles that engulf and degrade only a restricted set of cellular proteins [7]. Additional 
studies are clearly needed to resolve this uncertainty. Viruses 2011, 3                                       
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3. The Unfolded Protein Response Induces Autophagy 
Several viruses have been reported to induce a cellular ER stress response, also termed the unfolded 
protein response (UPR) [71], that, in turn, can induce autophagy [4,44,46,72-75]. The UPR might be 
triggered by viral polyprotein synthesis or viral replication in the ER or ER-derived structures [71]. 
The  UPR  response  allows  infected  cells  to  recover  from  ER  stress  by  attenuating  translation  and  
up-regulating the expression of chaperone proteins and degradation factors that refold or eliminate 
misfolded  proteins  [71].  Several  independent  studies  suggest  that  HCV  induces  the  UPR  in  vitro 
[44,46,76,77] and that it is detectable in liver biopsies of HCV infected patients [78] but the molecular 
mechanism(s) responsible for UPR induction by HCV is unclear. For example, the isolated expression 
of NS4B, a viral protein involved in formation of the HCV replication complex [79-81], induces the 
UPR via transactivation of ATF6 and IRE1-XBP1 [76,82]. Alternatively, the viral E2 glycoprotein 
possesses  a  retention  motif  in  its  transmembrane  domain  that,  in  complex  with  the  viral  E1 
glycoprotein, mainly resides in the ER [83] where it could form aggregates that contribute to ER stress 
activation [84]. Consistent with previous observations [4,72-75], down-regulation of a variety of UPR 
modulators (e.g. PERK, IRE1α, CHOP and ATF6) inhibits HCV induced LC3-phosphatidylethanolamine 
conjugation,  a  hallmark  of  autophagic  vesicle  accumulation  [44,46].  By  analogy  to  the  proposed 
mechanism of autophagy induction by hypoxia-triggered UPR, one can speculate that HCV-induced 
enhancement of CHOP expression [44] might activate autophagy by up-regulating Atg5 and LC3B 
expression [74]. Alternatively, it is possible that HCV-induced eIF2α phosphorylation via PERK [46], 
in turn, may activate autophagy as previously reported [69,73]. Nonetheless HCV replication and HCV 
protein accumulation are reduced in cells in which UPR proteins are down-regulated [44,46]. Thus 
additional  studies  will  be  required  to  determine  if  HCV  protein(s)  or  HCV  RNA  modulate  the 
autophagy pathway directly, or indirectly by activating the UPR.  
4. The Autophagy Machinery Positively Regulates HCV Replication 
Several independent laboratories have reported that autophagy proteins, i.e., Beclin 1, LC3, Atg4B, 
Atg5, Atg7 and Atg12, are required for productive HCV infection [41-45]. Dissection of the individual 
steps of the HCV life cycle suggests that these proteins specifically modulate the onset of translation of 
incoming HCV RNA and, therefore, the establishment of HCV replication [41], an observation further 
confirmed by independent studies [43,44]. Additionally, Tanida et al. observed that the release of HCV 
core and infectious particles from infected cells is reduced in Beclin 1- and Atg7-down-regulated cells, 
and they proposed that, in addition to facilitating the initiation of viral replication, autophagy proteins 
also contribute to HCV particle assembly and/or egress [42].  
5. Regulation of Innate Immune Signaling by Autophagy Proteins 
Recognition  of  viral  RNA  by  innate  response  receptors  triggers  the  production  of  antiviral 
molecules, e.g., type 1 interferon (IFN-α and β) and inflammatory cytokines [85] that are critical to 
control  infection  and  to  potentiate  immune  responses.  Viral  RNAs  are  recognized  by  cytosolic 
receptors  (e.g.,  RIG-I,  MDA5,  NLRPs)  and  by  toll-like  receptors  (TLRs)  present  in 
endosomal/lysosomal compartments of the cell [85]. Importantly, autophagy proteins are emerging as Viruses 2011, 3                                       
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key regulators of the innate host response against viral infection by either activating or inactivating the 
induction of antiviral molecules in infected cells [6,86-91]. It is possible, therefore, that autophagy 
proteins can regulate the balance between the restriction of viral propagation and the pathogenetic 
potential  of  an  overly  strong  host  response  (reviewed  in  [7]).  For  example,  Atg5  represses  
RIG-I-triggered IFNα/β production in vesicular stomatitis virus (VSV)-infected cells [89,90]. Indeed, 
Journai et al. showed that Atg5-Atg12 conjugates interact with RIG-I and IFNβ promoter stimulator 1 
(IPS-1)  (also  called  mitochondrial  antiviral  signaling  proteins  (MAVS),  virus-induced  signaling 
adaptor  (VISA)  or  CARD  adaptor-inducing  IFNβ  (Cardif)),  a  downstream  partner  of  RIG-I  that 
transmits signaling via interaction of their caspase recruitment domains (CARDs) [89]. The authors 
propose that the Atg5-Atg12 conjugate intercalates between the RIG-I and IPS-1 CARD domains and 
inhibits  signal  transduction,  thereby  suppressing  type  I  IFN  production  [89].  Other  observations 
suggest  that  autophagy  limits  RIG-I-induced  type  I  IFN  promoter  activation  via  the  clearance  of 
dysfunctional mitochondria and the attendant reduction in reactive oxygen species (ROS) production 
[90].  Additionally,  Soucy-Faulkner  et  al.  demonstrated  that  NOX2,  an  NADPH  oxidase  (NOX) 
enzyme that liberates cellular ROS, positively controls RIG-I-mediated signaling by regulating MAVS 
expression [92]. Consistent with these previous reports, Ke and Chen showed that down-regulation of 
Atg5 markedly increased IFNβ promoter activation triggered by overexpression of a constitutively 
active RIG-I mutant in vitro [44]. IFNβ and ISG expression induced by transfection of the HCV-
PAMP RNA, consisting of a homopolymeric uridine and cytidine (poly-U/UC) motif in the 3′ UTR of 
the HCV genome that has been identified as a major RIG-I-ligand [93,94], was also greatly potentiated 
in Atg5 and LC3 knockdown cells [44]. Using immortalized human hepatocytes, Shrivastava et al. also 
proposed  that  Beclin  1  and  Atg7  decreased  IFNβ  and  ISG  expression  [45].  Interestingly,  using 
lysosome-associated membrane protein 2 (LAMP2)- and Rab7-down-regulated cells, Ke and Chen 
demonstrated  that  autolysosome  maturation  is  required  to  repress  HCV-PAMP-induced  RIG-I 
signaling  [44].  Moreover,  UPR  modulators  (i.e.,  CHOP,  IRE1α,  ATF6  and  PERK)  limit  RIG-I-
mediated induced signaling, and chemical induction of the UPR and autophagy reciprocally decrease 
this signaling [44]. Since similar results were obtained with RIG-I-mediated signaling triggered by a 
Dengue virus genome-derived poly-U sequence [44], collectively, these results suggest that autophagy 
and  UPR  regulators  play  an  important  role  in  suppressing  antiviral  signaling  induced  by  PAMPs 
derived  from  members  of  the  flaviviridae  [44].  Based  on  these  results  and  previous  studies 
demonstrating that autophagy proteins limit VSV-induced IFN signaling, it appears that autophagy-
mediated repression of IFNβ and ISG expression extends to a broad spectrum of RIG-I ligands, in 
multiple cell types, and host species [89,90].  
Nonetheless,  HCV  aborts  the  RIG-I-induced  innate  immune  response  by  NS3/4A-dependent 
proteolysis  of  IPS-1  [95-98]  which,  together  with  a  currently  undefined  NS3/4A-independent 
inhibitory mechanism [99], blocks the induction of IFNβ and IFN stimulated genes (ISGs) in HCV-
infected cells [99,100]. In agreement with this observation, Ke and Chen showed that HCV infection 
itself (i.e., in the absence of RIG-I overexpression and HCV PAMP transfection) does not trigger IFNβ 
and ISG expression, even in autophagy protein-deficient cells [44]. Additionally, autophagy proteins 
are also required for HCV propagation in Huh-7.5.1 cells that are deficient for RIG-I signaling [101]. 
Thus, the extent to which amplification of RIG-I signaling by autophagy proteins accounts for reduced 
HCV replication in autophagy protein-deficient cells remains unclear at present, perhaps suggesting Viruses 2011, 3                                       
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that autophagy proteins control HCV replication by RIG-I-independent mechanisms as well. 
6. Dynamic Membrane Remodeling by the Autophagy Machinery 
As  a  dynamic  membranous  process,  autophagy  has  been  proposed  to  produce  a  scaffold  for 
intracellular membrane-associated, replication factories for RNA viruses that, like HCV, are known to 
replicate  and  assemble  on  cytoplasmic  membranes.  Evidence  suggests  that  some  viral  RNA 
replication/transcription  complexes,  e.g.,  for  nidoviruses  and  rotaviruses,  are  anchored  on  double 
membrane vesicles (DMVs) that resemble autophagosomes and are decorated with LC3 [64,102-111]. 
In  contrast,  confocal  microscopic  analysis  of  HCV-infected  cells  provides  little  evidence  of 
colocalisation of LC3 and viral proteins [41,42,46,59]. Nonetheless, by discontinuous sucrose gradient 
analysis, Ferraris et al. detected DMVs in fractions containing HCV RNA and proteins that apparently 
co-sedimented with LC3 [68]. Interestingly, they further showed by immuno-EM analysis of HCV 
subgenomic replicon cells, that some DMVs contain the HCV NS5A protein [68]. These observations 
suggest that, in HCV replicating cells, some viral elements may be present in structures resembling 
autophagic vesicles [68]. Additionally, Guevin et al. reported, in a heterologous yeast system, that the 
HCV NS5B RNA-dependent RNA polymerase interacts with ATG5 [43] via a highly conserved patch 
of basic amino acids at its C-terminus [112]. Moreover, they detected strong colocalization between 
NS5B and ATG5 that is temporally restricted to early time points of infection [43], suggesting that 
NS5B/ATG5  interaction  could  be  necessary  for  the  establishment  of  HCV  replication  but  not  to 
maintain it. This is consistent with earlier observations from our laboratory that key regulators of 
autophagic vesicle formation are required to initiate translation and replication of incoming viral HCV 
RNA in de novo infected cells, but they are not required to maintain this process once viral replication 
is established [41]. Collectively, these results suggest that the host factors required for translation of 
the incoming viral RNA are distinct from those necessary for translation and replication of progeny 
HCV RNA and that some of those host factors are autophagy proteins [41,113].  
The origin of the autophagosomal membrane is still a pending question. Nonetheless, several recent 
studies  suggest  that  the  ER  is  crucial  for  autophagosome  formation,  since  autophagy  proteins  are 
recruited to certain domains of the ER or to closely attached structures and direct connections between 
the  ER  and  autophagosomal  membranes  have  been  demonstrated  [114-120].  By  remodeling  ER 
membranes, autophagy proteins or autophagic vesicles might provide an initial membranous support 
for translation and replication of incoming RNA, prior to accumulation of viral proteins and before the 
eventual establishment of HCV-induced cellular modifications [10]. Alternatively, it is possible that 
autophagy proteins contribute to the cytoplasmic transport of the incoming viral RNA to the translation 
apparatus, a hitherto unstudied step of HCV infection that, by its unique nature, could be different for 
incoming RNA vs. progeny viral RNA produced during viral replication. Future work will be needed 
to better understand this interplay. Nonetheless, it is conceivable that a restricted subset of autophagy 
markers may localize transiently at the site of HCV translation and replication. In support of this 
concept,  only  non-lipidated-LC3  has  been  detected  at  the  site  of  mouse  hepatitis  virus  (MHV) 
replication [111]. For this virus, the formation of double membrane vesicles where replication occurs 
relies on LC3 and intersects with ER-associated degradation (ERAD) machinery [111], illustrating that Viruses 2011, 3                                       
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viruses can utilize autophagy proteins and structures that resemble autophagic vesicles independently 
of the conventional autophagy pathway.  
7. Conclusions and Future Directions 
In summary, the interrelationship between the autophagy machinery and HCV has emerged as a 
highly active research area and there is now little doubt that HCV utilizes autophagy proteins for its 
propagation [41-45]. It is also clear that vesicles with characteristic features of autophagic vacuoles 
accumulate in HCV infected cells [41-44,46,68]. Importantly, consistent with the ability of HCV to 
induce autophagy in infected cells in vitro and supportive of the physiological and clinical relevance of 
the in vitro studies discussed in this review, Rautou et al. recently reported evidence for an increased 
autophagic response in the liver of chronically HCV infected patients relative to the normal liver and 
to patients with nonalcoholic steatohepatitis, alcoholic liver disease, and chronic hepatitis B infection 
[121]. Mechanism(s) are beginning to emerge to explain how HCV regulates the autophagy pathway 
[44,46] and how it exploits autophagy proteins to initiate replication of the incoming viral genome 
[41,43]  and  to  attenuate  RIG-I  signaling  [44,45].  Further  work  will  be  necessary  to  reconcile  our 
fragmented and sometimes conflicting understanding of the role of autophagy in HCV infection. In 
particular,  much  remains  to  be  learned  about  the  spatio-temporal  appearance  and  composition  of 
vesicles resembling autophagosomes in HCV-infected cells. Autophagy has long been considered as a 
random  cytoplasmic  degradation  process,  but  it  is  now  clear  that  autophagosomes  can  degrade 
substrates in a selective manner. In particular, ubiquitin and/or specific adaptor proteins could provide 
selectivity for degradation by autophagy [122,123]. As we learn (i) the identity of membrane donors 
from  which  autophagy  vesicles  are  formed  in  HCV  infected  cells,  (ii)  the  nature  of  the  cellular 
organelles  and/or  protein  aggregates  engulfed  in  these  vesicles,  and  (iii)  the  extent  to  which  they 
resemble  or  differ  from  canonical  autophagic  vesicles,  we  will  better  understand  how  autophagy 
proteins can regulate HCV replication and propagation. 
Finally,  the  recent  demonstration  that  pharmacologic  modulation  of  autophagy  augments  the 
efficacy of currently available anticancer regimens [124] and the possibility that autophagy may be a 
legitimate  target  for  the  development  of  antimicrobial  drugs  [125,126]  are  very  exciting  areas  in 
biomedical  research.  It  is  conceivable  that  inhibition  of  autolysosome  maturation  may,  directly  or 
indirectly via increased  RIG-I signaling, repress HCV propagation. Nonetheless, it is important to 
recognize that our current understanding of the role of the autophagy machinery in the propagation and 
control  of  virus  infections  is  in  its  infancy,  and  much  more  work  must  be  done  before  we  can 
confidently translate these results into new approaches for the treatment of this serious and widespread 
human disease. 
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